Moriarity BS[au] - Search Results

Year	Number of Results
2011	1
2012	2
2013	4
2014	5
2015	6
2016	7
2017	7
2018	8
2019	10
2020	11
2021	9
2022	5

1

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.

Li Y, Hermanson DL, Moriarity BS, Kaufman DS. Li Y, et al. Among authors: moriarity bs. Cell Stem Cell. 2018 Aug 2;23(2):181-192.e5. doi: 10.1016/j.stem.2018.06.002. Epub 2018 Jun 28. Cell Stem Cell. 2018. PMID: 30082067 Free PMC article.

2

CRISPR/Cas9 library screening for drug target discovery.

Kurata M, Yamamoto K, Moriarity BS, Kitagawa M, Largaespada DA. Kurata M, et al. Among authors: moriarity bs. J Hum Genet. 2018 Feb;63(2):179-186. doi: 10.1038/s10038-017-0376-9. Epub 2017 Nov 20. J Hum Genet. 2018. PMID: 29158600 Review.

3

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.

Pomeroy EJ, Hunzeker JT, Kluesner MG, Lahr WS, Smeester BA, Crosby MR, Lonetree CL, Yamamoto K, Bendzick L, Miller JS, Geller MA, Walcheck B, Felices M, Webber BR, Starr TK, Moriarity BS. Pomeroy EJ, et al. Among authors: moriarity bs. Mol Ther. 2020 Jan 8;28(1):52-63. doi: 10.1016/j.ymthe.2019.10.009. Epub 2019 Oct 15. Mol Ther. 2020. PMID: 31704085 Free PMC article.

4

A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers.

Wong DP, Roy NK, Zhang K, Anukanth A, Asthana A, Shirkey-Son NJ, Dunmire S, Jones BJ, Lahr WS, Webber BR, Moriarity BS, Caimi P, Parameswaran R. Wong DP, et al. Among authors: moriarity bs. Nat Commun. 2022 Jan 11;13(1):217. doi: 10.1038/s41467-021-27853-w. Nat Commun. 2022. PMID: 35017485 Free PMC article.

5

Nonviral genome engineering of natural killer cells.

Robbins GM, Wang M, Pomeroy EJ, Moriarity BS. Robbins GM, et al. Among authors: moriarity bs. Stem Cell Res Ther. 2021 Jun 16;12(1):350. doi: 10.1186/s13287-021-02406-6. Stem Cell Res Ther. 2021. PMID: 34134774 Free PMC article. Review.

6

The Molecular Imaging of Natural Killer Cells.

Shapovalova M, Pyper SR, Moriarity BS, LeBeau AM. Shapovalova M, et al. Among authors: moriarity bs. Mol Imaging. 2018 Jan-Dec;17:1536012118794816. doi: 10.1177/1536012118794816. Mol Imaging. 2018. PMID: 30203710 Free PMC article. Review.

7

C-to-U RNA Editing: From Computational Detection to Experimental Validation.

Lerner T, Kluesner M, Tasakis RN, Moriarity BS, Papavasiliou FN, Pecori R. Lerner T, et al. Among authors: moriarity bs. Methods Mol Biol. 2021;2181:51-67. doi: 10.1007/978-1-0716-0787-9_4. Methods Mol Biol. 2021. PMID: 32729074

8

CRISPR/Cas9-Mediated Genome Engineering of Primary Human B Cells.

Laoharawee K, Johnson MJ, Moriarity BS. Laoharawee K, et al. Among authors: moriarity bs. Methods Mol Biol. 2020;2115:435-444. doi: 10.1007/978-1-0716-0290-4_24. Methods Mol Biol. 2020. PMID: 32006415

9

Targeted genome editing for the correction or alleviation of primary Immunodeficiencies.

Sipe CJ, Claudio Vázquez PN, Skeate JG, McIvor RS, Moriarity BS. Sipe CJ, et al. Among authors: moriarity bs. Prog Mol Biol Transl Sci. 2021;182:111-151. doi: 10.1016/bs.pmbts.2021.03.001. Epub 2021 Apr 7. Prog Mol Biol Transl Sci. 2021. PMID: 34175040

10

Genome Engineering of Primary Human B Cells Using CRISPR/Cas9.

Laoharawee K, Johnson MJ, Lahr WS, Peterson JJ, Webber BR, Moriarity BS. Laoharawee K, et al. Among authors: moriarity bs. J Vis Exp. 2020 Nov 3;(165):10.3791/61855. doi: 10.3791/61855. J Vis Exp. 2020. PMID: 33226023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results